Gold X2 Mining Inc. 6-K filed 2026-09-10

Gold X2 Mining Inc. filed a Form 6-K with the SEC on 2026-09-10 under accession 0001062993-26-004881. A 6-K is the cover report a foreign private issuer uses to furnish the SEC with material it has already released elsewhere. The registrant gives its principal offices as 450 Commerce Place, 400 Burrard Street, Vancouver, British Columbia, and checked the box indicating it files annual reports on Form 40-F rather than Form 20-F. The filing carries a single exhibit, 99.1, a news release dated September 10, 2026 regarding drilling results, and is signed by Michael Kanevsky, Chief Financial Officer. The release covers assays from an ongoing resource expansion drilling program targeting the depth extensions of the QES Zone at the Moss Gold Project in Northwest Ontario, Canada. Its headline reports drilling that intersected 173.0m of 0.89 g/t Au roughly 100m beneath the RPEEE pit shell. CEO Michael Henrichsen is quoted saying that 12 of the 21 planned holes in the QES resource expansion program are complete and that further assay results are expected over the coming weeks. The campaign is described as targeting a depth of 75 to 100 meters below the current pit shell, with the stated aims of extending known mineralized shears, increasing drill density, upgrading in-pit Inferred resource blocks to Indicated, and supporting a possible expansion of the open pit to depth. For an analyst or reporter, the point of interest is that this is exploration drilling meant to remove a data constraint on the resource model, not a completed resource update. The company states that the deeper part of the resource is currently limited by sparse drill data and that new drilling is intended to define the pit by economic parameters instead. EDGAR classifies the registrant under SIC 1040, Gold and Silver Ores, lists tickers AUXX, GSHRD and GSHRF, and records a former name of Goldshore Resources Inc. The excerpt is the front of the filing and the exhibit's opening text. An updated mineral resource estimate, assay methodology and QA/QC disclosure, the full intercept and collar tables referenced as Tables 1 and 2, the figures, program cost and funding, and any financial statements are not in the filing as provided here. A reader who needs those should open the source filing.